These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12214337)

  • 1. [Treatment of non-alcoholic steatohepatitis (NASH). A comparative study of ursodeoxycholic acid and alpha-tocopherol. A preliminary report].
    Bernal-Reyes R; Escudero RB
    Rev Gastroenterol Mex; 2002; 67(2):70-5. PubMed ID: 12214337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study.
    Georgescu EF; Georgescu M
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):39-46. PubMed ID: 17410287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.
    Laurin J; Lindor KD; Crippin JS; Gossard A; Gores GJ; Ludwig J; Rakela J; McGill DB
    Hepatology; 1996 Jun; 23(6):1464-7. PubMed ID: 8675165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment.
    Ersöz G; Günşar F; Karasu Z; Akay S; Batur Y; Akarca US
    Turk J Gastroenterol; 2005 Sep; 16(3):124-8. PubMed ID: 16245220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for NASH: the value of histology.
    Elitsur Y; Lawrence Z; Wang R; Durst PR
    Am J Gastroenterol; 2005 Jan; 100(1):250-1. PubMed ID: 15654810
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis.
    Dufour JF; Oneta CM; Gonvers JJ; Bihl F; Cerny A; Cereda JM; Zala JF; Helbling B; Steuerwald M; Zimmermann A;
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1537-43. PubMed ID: 17162245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review.
    Xiang Z; Chen YP; Ma KF; Ye YF; Zheng L; Yang YD; Li YM; Jin X
    BMC Gastroenterol; 2013 Sep; 13():140. PubMed ID: 24053454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of NASH with ursodeoxycholic acid: cons.
    Liechti F; Dufour JF
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S46-52. PubMed ID: 23141894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of NASH with ursodeoxycholic acid: pro.
    Ratziu V
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S41-5. PubMed ID: 23141893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.
    Kiyici M; Gulten M; Gurel S; Nak SG; Dolar E; Savci G; Adim SB; Yerci O; Memik F
    Can J Gastroenterol; 2003 Dec; 17(12):713-8. PubMed ID: 14679419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial comparing the effects of Vitamin E, Ursodeoxycholic acid and Pentoxifylline on Egyptian non-alcoholic steatohepatitis patients.
    Fouda A; Abdelaziz AE; Hussien M; Ali AA; Abdelkawy KS; Elbarbry F
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7449-7459. PubMed ID: 34919247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial.
    Lindor KD; Kowdley KV; Heathcote EJ; Harrison ME; Jorgensen R; Angulo P; Lymp JF; Burgart L; Colin P
    Hepatology; 2004 Mar; 39(3):770-8. PubMed ID: 14999696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bezafibrate treatment of primary biliary cirrhosis following incomplete response to ursodeoxycholic acid.
    Hazzan R; Tur-Kaspa R
    J Clin Gastroenterol; 2010; 44(5):371-3. PubMed ID: 19881358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ursodeoxycholic acid therapy on carotid intima media thickness, apolipoprotein A1, apolipoprotein B, and apolipoprotein B/A1 ratio in nonalcoholic steatohepatitis.
    Ozel Coskun BD; Yucesoy M; Gursoy S; Baskol M; Yurci A; Yagbasan A; Doğan S; Baskol G
    Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):142-9. PubMed ID: 25533429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis.
    Ratziu V; de Ledinghen V; Oberti F; Mathurin P; Wartelle-Bladou C; Renou C; Sogni P; Maynard M; Larrey D; Serfaty L; Bonnefont-Rousselot D; Bastard JP; Rivière M; Spénard J;
    J Hepatol; 2011 May; 54(5):1011-9. PubMed ID: 21145828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of primary biliary cirrhosis with ursodeoxycholic acid].
    Nikolovska D; Vasilev P; Mikhova A
    Vutr Boles; 2000; 32(1):25-7. PubMed ID: 11195193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of ursodeoxycholic acid (UDCA) in the treatment of chronic alcoholic hepatitis].
    Preobrazhenskiĭ VN; Taianovskiĭ VIu
    Klin Med (Mosk); 1998; 76(5):26-8. PubMed ID: 9644931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic steatohepatitis.
    Kumar KS; Malet PF
    Mayo Clin Proc; 2000 Jul; 75(7):733-9. PubMed ID: 10907390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.
    Talwalkar JA; Angulo P; Keach JC; Petz JL; Jorgensen RA; Lindor KD
    J Clin Gastroenterol; 2005 Feb; 39(2):168-71. PubMed ID: 15681915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid and artesunate in the treatment of severe falciparum malaria patients with jaundice.
    Treeprasertsuk S; Silachamroon U; Krudsood S; Huntrup A; Suwannakudt P; Vannaphan S; Wilairatana P
    J Gastroenterol Hepatol; 2010 Feb; 25(2):362-8. PubMed ID: 19817958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.